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Why do we need “networks” in systems medi-
cine? Maybe there is not a simple answer. 
Until recently, scientists from mathematics, 
physics, statistics, machine learning, com-
puter science, and similar quantitative/
computational disciplines were converg-
ing to bioinformatics for known reasons. 
A main one was to support the experimen-
tal and theoretical work of their colleagues 
in medicine and biology requiring specific 
data analysis and inference methods in 
applications from complex biomedical sys-
tems. Another reason was to address more 
rigorously problems producing only scarce 
data, and thus prone to insufficient infor-
mation extraction and interpretation. The 
paradigm of “doing more with what is avail-
able” remained in equilibrium until the next 
generation technologies appeared to face 
the “omics” challenges, and soon became 
the elected tools for scientific discovery.
The sign that such “technological dis-
continuity” is transforming research and 
inducing shifts of paradigms at experimen-
tal, methodological, and applied levels, is 
testified by the impulses – if not shocks – 
given to the associated computational 
disciplines. Such non-smooth transition 
has created the conditions for generat-
ing a new hybrid “scientific landscape” 
covering a knowledge spectrum unmet 
before through conventional disciplines 
and approaches. This landscape is hard to 
walk because basically endless in terms of 
challenges. The involved complexities con-
cern problem indeterminacy, inaccuracy of 
measurements, and unknown uncertainty. 
To be able to at least bypass such bottle-
necks, new integrative inference approaches 
must be designed based on qualitative and 
quantitative components fused into possi-
ble “targets.”
Networks address such needs and 
have naturally acquired a central role in 
the mentioned landscape. Many types of 
biological networks exist, examples being 
gene regulatory, protein–protein interac-
tion, metabolic, signaling ones. While such 
diversity has requested particular methods 
and inference approaches in each appli-
cation context, it did not prevent from 
observing common features, especially 
at a topological level (small world, scal-
ing laws, etc.). Biomedical systems are 
measured in both physical and functional 
terms, and often embed “targets” to be 
identified, visualized in their contextual 
environment, and recovered for further 
analysis. Networks are static representa-
tions of the associations (links) between 
biological variables (nodes). When causa-
tive associations are present, then regula-
tory dynamics can be inferred. Instead, 
when the associations can only establish 
the presence of “communication” without 
defining directionality, then interactive 
dynamics are represented. Node-entities 
such as genes or proteins and their edge-
based relationships allow the simultaneous 
investigation of both temporal and spatial 
information. Spatiotemporal dynamics are 
usually lacking in network maps, replaced 
by averages taken over conditions or time 
points. This limitation reduces the inher-
ent potential of networks to emphasize 
roles and functions of co-existing entities 
through their causal relationships, while 
monitoring the information transmission 
mechanisms, including phenotypic altera-
tions, that signaling processes activate at 
systems’ level. Multidimensionality is cru-
cial for establishing a dynamic network 
approach based on the study of coordi-
nated spatiotemporal signaling networks 
and pathways activation.
For application in systems medicine 
(Auffray et al., 2009), two other factors 
need to be included: implementation of 
a “computational multiplexing strategy” 
(Welch et al., 2011) and translation of sys-
tems responses to the clinic. The first fac-
tor implies steps such as the integration of 
heterogeneous data and variables types (sig-
nals, images, omics, and clinical variables), 
and the application of computational tools 
that can model their complex relationships 
and transform this knowledge into predic-
tion power. Computational inference meth-
ods (Bayesian ones, for instance) may define 
the nature of the “omics-clinics” integration 
by casting it within efficient models. The 
second factor is instead assigning to sys-
tems biology an active role in changing the 
medical paradigms, in particular by foster-
ing predictive, personalized, and preventive 
developments.
Dynamic networks are useful for the 
analysis of disease processes (Barabasi 
et al., 2011). Rather than individual genes 
and proteins, pathways and “functional 
modules” can be used for target identifi-
cation in drug development studies, bio-
marker discovery, disease classification, 
etc. In particular, “differential network 
analysis” (Ideker and Krogan, 2012) may 
be established by comparing topological 
architectures and modular structures in 
health versus disease states, or between 
two different disease states, often with the 
support of expression, genetic, and clini-
cal information (Cabusora et al., 2005). 
The expected variation may reflect the 
distinctiveness in molecular signatures of 
gene expression and protein translation 
arising from different combinations of 
genetic mutations. Once such signatures 
are assigned to network nodes, topological 
and biological features may elucidate inter-
actions and causal relationships. Targeting 
altered signaling networks can suggest 
novel “network medicine”-based (Pawson 
and Linding, 2008; Zanzoni et al., 2008) 
therapy approaches, where the focus moves 
from individual targets to combined/com-
binatorial target dynamics.
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The dynamic property of networks can-
not be isolated from gene expression and 
pathway activation. Transcriptome inference, 
particularly in the context of the spectrum 
of expression levels leveraged by RNA-Seq 
features (Wang et al., 2009), i.e., depth of 
coverage, accurate quantification, high 
reproducibility, increased capture power 
of differential values, and also identifica-
tion (and diversity) of alternative-spliced 
isoforms (Marioni et al., 2008), can eluci-
date the possible causes behind changes in 
the organization structure assessed at net-
work topology scale. Even if the correlation 
between transcriptional and network pro-
files is not completely predictable due to the 
action of control/regulation mechanisms at 
both levels, a wealth of information comes 
from several different gene-encoded vari-
ants and from post-translational modifica-
tions involved in key proteins.
Scrutinizing “transcriptome profiles” 
over time and coupling it with “network 
configuration profiles” to find possible cor-
related patterns has great potential together 
with limitations. Such coupling (or uncou-
pling) could be tissue-dependent, thus a 
variety of studies should be performed. 
Then, regulatory roles of “non-coding RNA” 
or insight on possible “gene extensions” 
could be key, but not much is currently 
known about many types of transcript 
structures. However, these complexities may 
be monitored by looking at the changes in 
network configurations at both module and 
pathway scales. Such scales are inherently 
applying the principle of dimensionality 
reduction to high-dimensional integrative 
networks, as the most significant (dense) 
information kernels can be cohesively rep-
resented (Capobianco et al., 2011).
The sort of prediction power underlying 
the transcriptome could be assessed follow-
ing the transfer of network dynamics into 
new associations (aggregation of separate 
interactions) and dissociations (break 
down) of modular structures. One could 
qualify such changes in transient or perma-
nent terms (for instance, the constitutive 
components forming the core of pathway/
complexes that change dynamically due to 
module addition/subtraction). Intuitively, a 
natural quantity to monitor is the degree of 
participation in “network activities” by all 
its constituent entities, and assuming that 
each module has a functional (i.e., biologi-
cally relevant) value. Thus, one objective is 
to check how differential conditions affect 
the participation to modules, which in top-
ological terms means that properties such 
as betweenness and vertex–vertex distances 
should tell how the dynamics induce a local-
ized or global re-positioning of vertexes in 
the network.
Maybe there is no simple answer to why 
networks are pervasive in systems medicine 
work; however, there are many good reasons 
to believe that their centrality is destined to 
grow, making them become bright stars for 
years to come.
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